Patents Examined by Paul Prebilic
  • Patent number: 9717585
    Abstract: An endovascular apparatus is provided for treating the effects of vascular disease including aneurysms and arterial blockages using a percutaneous, minimally invasive technique. In one embodiment the endovascular apparatus includes a tubular sleeve having a cranial end, a first caudal branch, and a second caudal branch such that the tubular sleeve is shaped like an upside down “Y.” The apparatus further—includes at least one expandable attachment device attached to the tubular sleeve for securing the endovascular apparatus to an interior wall of a vessel. The at least one expandable attachment device includes a plurality of telescoping segments similar to the telescoping segments of a presentation pointer. Accordingly, during percutaneous insertion of the endovascular apparatus into a patient the attachment device can be collapsed into a small profile. Once positioned at the site of the aneurysm the telescoping attachment device can be expanded to hold the endovascular apparatus in place.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: August 1, 2017
    Assignee: TMT SYSTEMS
    Inventor: Timur P. Sarac
  • Patent number: 9713532
    Abstract: A femoral augment for use with a knee joint prosthesis, where the femoral augment includes a main body portion, an aperture formed within the main body portion and extending in a generally distal/proximal direction, and a pair of legs extending outwardly from said main body portion in a generally posterior direction. In the preferred embodiment, the aperture is configured to receive a stem extension implant, and to allow it to pass through. Additionally, the legs of the femoral augment are preferably configured to be seated proximal of a proximal side of a pair of condylar portions of a femoral component of a knee joint prosthesis. The present invention is intended for situations in which the distal portion of the femur is defective, and it provides a method and devices that allow for preservation of healthy peripheral bone, while still providing the necessary augmentation to the distal portion of fee femur.
    Type: Grant
    Filed: May 27, 2015
    Date of Patent: July 25, 2017
    Assignee: Zimmer, Inc.
    Inventors: Jeff Blaylock, Michael Cook, Ron Donkers, Scott Dykema, Maleata Hall, John E. Meyers, Arlen D. Hanssen, David Lewallen
  • Patent number: 9713527
    Abstract: The invention relates to a multi-lens intraocular lens system having an accommodation material between the lenses. The system comprises an posterior lens attached to the posterior surface of the capsular bag and an anterior lens attached to the anterior surface of the capsular bag. The anterior and posterior lenses have different optical properties providing different degrees and types of correction. An accommodation material is place between the anterior and posterior lenses. The accommodation material may comprise of one or more macromers, which, when polymerized, adjust the properties of the accommodation material.
    Type: Grant
    Filed: July 20, 2006
    Date of Patent: July 25, 2017
    Assignee: RxSight, Inc.
    Inventors: Okihiro Nishi, Kayo Nishi, Shiao H. Chang, Jerry Kaeni
  • Patent number: 9700409
    Abstract: A prosthetic heart valve may include a stent body with a plurality of cells arranged in circumferential rows and a cuff attached to the stent. A leaflet attachment panel may be attached to and span a portion of one of the cells. A prosthetic valve element, such as a leaflet having a belly, may be mounted to the leaflet attachment panel. The leaflet attachment panel may not be integral with the stent body. A reduced overlap area may be defined between a proximal end of the stent body and a proximalmost point of attachment of the leaflet belly to the cuff. The reduced overlap area may have a size dependent upon the circumferential row of cells the leaflet attachment panel is attached to and a position of the portion of the leaflet attachment panel to which the leaflet is mounted. Alternately, the leaflet may be attached directly to the stent.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: July 11, 2017
    Assignee: St. Jude Medical, Cardiology Division, Inc.
    Inventors: Peter N. Braido, Kent J. Smith
  • Patent number: 9675455
    Abstract: A prosthetic heart valve having an internal support frame with a continuous, undulating leaflet frame defined therein. The leaflet frame has three cusp regions positioned at an inflow end intermediate three commissure regions positioned at an outflow end thereof. The leaflet frame may be cloth covered and flexible leaflets attached thereto form occluding surfaces of the valve. The support frame further includes three cusp positioners rigidly fixed with respect to the leaflet frame and located at the outflow end of the support frame intermediate each pair of adjacent commissure regions. The valve is desirably compressible so as to be delivered in a minimally invasive manner through a catheter to the site of implantation. Upon expulsion from catheter, the valve expands into contact with the surrounding native valve annulus and is anchored in place without the use of sutures.
    Type: Grant
    Filed: March 4, 2016
    Date of Patent: June 13, 2017
    Assignee: Edwards Lifesciences Corporation
    Inventor: Mario Iobbi
  • Patent number: 9669141
    Abstract: The present invention provides tissue-engineered pumps and valves, methods of fabricating such pumps and valves, and methods of use of such pumps and valves.
    Type: Grant
    Filed: July 19, 2013
    Date of Patent: June 6, 2017
    Assignees: President and Fellows of Harvard College, California Institute of Technology
    Inventors: Kevin Kit Parker, Josue A. Goss, Sung-Jin Park, Andrew K. Capulli, Holly M. Golecki, Janna C. Nawroth, John O. Dabiri
  • Patent number: 9662233
    Abstract: An artificial blood vessel is a tubular fabric including a fiber layer containing an ultrafine fiber(s) and an ultrafine fiber layer in the inside of the fiber layer, the ultrafine fiber layer being composed of an ultrafine fiber(s) having a fiber diameter(s) of not less than 10 nm and not more than 3 ?m, wherein a quaternary ammonium group-containing polymer having alkyl groups each of a carbon number 10 or less is covalently bound to the ultrafine fiber(s); heparin is ionically bound to the quaternary ammonium group-containing polymer; and the residual heparin activity after washing with physiological saline at 37° C. for 30 minutes is 20 mIU/cm2 or more.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: May 30, 2017
    Assignee: Toray Industries, Inc.
    Inventors: Kazuhiro Tanahashi, Yuka Sakaguchi, Masaki Fujita, Koji Kadowaki, Hiroshi Tsuchikura, Satoshi Yamada
  • Patent number: 9642695
    Abstract: In order to provide an artificial blood vessel that can prevent formation of a thrombus and a method for producing the artificial blood vessel, an artificial blood vessel is used (i) in which a peptide including a specific amino acid sequence has been added to an extracellular matrix obtained from a bio-derived vascular tissue and (ii) whose lumen has a cross sectional diameter of 4 mm or less.
    Type: Grant
    Filed: September 5, 2013
    Date of Patent: May 9, 2017
    Assignee: JMS CO., LTD.
    Inventors: Tetsuji Yamaoka, Atsushi Mahara
  • Patent number: 9642699
    Abstract: Prosthetic capsular devices (e.g., bag, bowl, housing, structure, cage, frame) include technology devices such as a computer, virtual reality device, display device, WiFi/internet access device, image receiving device, biometric sensor device, game device, image viewers or senders, GPSs, e-mail devices, combinations thereof, and/or the like. The technology devices can be used in combination with an intraocular lens. The output from the technology device(s) can be fed to the retina of the user to provide a visual image, can be otherwise connected to the user, and/or can be used to control the properties of the intraocular lens or of the prosthetic capsular device.
    Type: Grant
    Filed: August 3, 2016
    Date of Patent: May 9, 2017
    Assignee: Omega Ophthalmics LLC
    Inventors: Gary N. Wortz, Rick William Ifland
  • Patent number: 9638936
    Abstract: Contact lenses incorporate high plus or add power profiles that at least one of slow, retard or preventing myopia progression and minimize halo effect. The lens includes a center zone with a negative power for myopic vision correction; and at least one treatment zone surrounding the center zone, the at least one treatment zone having a power profile that increases from an outer margin of the center zone to a positive power within the at least one treatment zone of greater than +5.00 D.
    Type: Grant
    Filed: August 20, 2014
    Date of Patent: May 2, 2017
    Assignee: Johnson & Johnson Vision Care, Inc.
    Inventors: Noel A. Brennan, Khaled A. Chehab, Xu Cheng, Michael J. Collins, Manwai Charis Lau, Eric R. Ritchey, Xin Wei
  • Patent number: 9636212
    Abstract: The object of providing a device for reversibly attaching an implant to an eye, with which the implant can be attached in a simple way to the eye and can if necessary be detached or removed from the eye, is achieved according to the present invention by means of a device for attaching an implant by means of a pin that comprises a substantially elongated shaft, wherein the implant includes an implant film for contacting living tissue or nerves in the visual system of the eye and the implant film has an opening through which the shaft of the pin can be at least partially inserted, characterised in that the device includes a holding element that can be arranged on the shaft of the pin so that the holding element engages on the shaft of the pin and is fixed in an attachment position to the pin.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: May 2, 2017
    Assignee: PIXIUM VISION SA
    Inventors: Hans-Jürgen Tiedtke, Alexander Meyer
  • Patent number: 9636215
    Abstract: Systems and methods are provided for improving overall vision in patients suffering from a loss of vision in a portion of the retina (e.g., loss of central vision) by providing an enhanced toric lens which redirects and/or focuses light incident on the eye at oblique angles onto a peripheral retinal location. The intraocular lens can include a redirection element (e.g., a prism, a diffractive element, or an optical component with a decentered GRIN profile) configured to direct incident light along a deflected optical axis and to focus an image at a location on the peripheral retina. Optical properties of the intraocular lens can be configured to improve or reduce peripheral errors at the location on the peripheral retina. One or more surfaces of the intraocular lens can be a toric surface, a higher order aspheric surface, an aspheric Zernike surface or a Biconic Zernike surface to reduce optical errors in an image produced at a peripheral retinal location by light incident at oblique angles.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: May 2, 2017
    Assignee: AMO GRONINGEN B.V.
    Inventors: Robert Rosen, Hendrik A Weeber, Carmen Canovas Vidal, Marrie Van Der Mooren, Dora Sellitri
  • Patent number: 9622855
    Abstract: An ophthalmic multifocal switchable lens includes a deformable element manifesting elevated strain with a formable surface of a multifocal surface shape to provide far and near vision. A transparent chamber is filled with optical matching fluid adjacent to the side of the deformable element opposite to the formable surface. The optical matching fluid has a refractive index that matches a refractive index of the deformable element material. A holding chamber is also filled with the optical matching fluid and connected with the transparent chamber with a means for preventing the optical fluid from being transported from the holding chamber to the transparent chamber which would reduce a strain of the deformable element. A split of light between far and near vision of the multifocal switchable lent changes upon a removal of the means to allow a flow of the optical matching fluid into the transparent chamber.
    Type: Grant
    Filed: September 27, 2013
    Date of Patent: April 18, 2017
    Inventors: Valdemar Portney, Nathaniel G. Portney
  • Patent number: 9622887
    Abstract: A stent graft has a cylindrical wall, an internal lumen within the cylindrical wall and a fenestration in the wall. The fenestration is closed off by a valve arrangement to prevent the flow of liquids from within the internal lumen to outside of the wall. The valve arrangement is a tube of graft material which can be closed off by pressure on its outside surface. The end of the tube remote from the fenestration can be held shut by having its periphery fastened to a flattened resilient ring. Fluid pressure on the tube of graft material causes the tube to close off to prevent fluid flow therethrough and by resilient deflection of the resilient ring the end of the tube of graft material can be opened to enable the passing of a medical device therethrough.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: April 18, 2017
    Assignee: Cook Medical Technologies LLC
    Inventors: Werner D. Ducke, Chantelle King
  • Patent number: 9622856
    Abstract: An intraocular lens for providing a subject with vision at various distances includes an optic having a first surface with a first shape, an opposing second surface with a second shape, a multifocal refractive profile, and one or more diffractive portions. The optic may include at least one multifocal diffractive profile. In some embodiments, multifocal diffractive and the multifocal refractive profiles are disposed on different, distinct, or non-overlapping portions or apertures of the optic. Alternatively, portions of the multifocal diffractive profiles and the multifocal refractive profiles may overlap within a common aperture or zone of the optic.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: April 18, 2017
    Assignee: Abbott Medical Optics Inc.
    Inventors: Hendrik A Weeber, Patricia Ann Piers, Mark H Bandhauer, Marrie H Van Der Mooren, Huawei Zhao
  • Patent number: 9615947
    Abstract: An artificial blood vessel that can be transplanted to blood vessels with a small diameter, can be adjusted to an arbitrary size of a diameter, improves in invasiveness when a graft is taken, and overcomes the problem on the provision of a graft is provided. An artificial blood vessel prepared from a decellularized tubular structure, which is prepared by processing a decellularized, sheet-like blood vessel (decellularized blood vessel sheet) into a roll structure, and a tissue adhesive, wherein a portion which is contacted with blood that flows within the artificial blood vessel consists of the tissue of the tunica intima lined with the tissue of the tunica media whereas a portion of the sheet that overlaps when the sheet is processed into a roll structure (overlap width) consists of the tissue of the tunica media and wherein a tissue adhesive is applied to the overlap width.
    Type: Grant
    Filed: December 17, 2013
    Date of Patent: April 11, 2017
    Assignee: THE CHEMO-SERO-THERAPEUTIC RESEARCH INSTITUTE
    Inventors: Noriko Shinya, Takanori Uchida, Akio Kishida, Tetsuya Higami
  • Patent number: 9603700
    Abstract: The present invention relates to an intracorneal lens (1), comprising a circular main body having a convex front surface and a convex rear surface, characterized in that the convex front surface has a single uniform radius of curvature (Rcv) and the concave rear surface has a radius of curvature (Rcci). The radius of curvature (Rcci) of the concave rear surface is greater than the average radius of the cornea by 0.1 mm to 2 mm, preferably 0.2 to 1.5 mm, in particular preferably 0.5 to 1 mm. The present invention further relates to a kit, comprising a storage unit (15) and a pre-load unit (P) inside the storage unit (15). The storage unit (15) is made of a watertight material and can be closed watertight by means of a plug (16). The pre-load unit (P) is fitted with the intracorneal lens according to the invention.
    Type: Grant
    Filed: May 7, 2013
    Date of Patent: March 28, 2017
    Assignee: PRESBIA IRELAND LIMITED
    Inventor: Werner Berner
  • Patent number: 9585778
    Abstract: Segmented scaffolds composed of disconnected scaffold segments with overlapping end rings are disclosed. Scaffolds with at least one discontinuous link are also disclosed.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: March 7, 2017
    Assignee: ABBOTT CARDIOVASCULAR SYSTEMS INC.
    Inventors: John E. Papp, Syed Faiyaz Ahmed Hossainy, Michael Ngo, Chad Abunassar, Boris Anukhin, Mikael Trollsas, Lewis B. Schwartz
  • Patent number: 9585749
    Abstract: A replacement heart valve assembly. An expandable anchor is disclosed that has a skirt region, a lip region, and a plurality of posts attached to the skirt region. A replacement heart valve is attached to the posts. The lip region has interlocking elements that are secured to the posts where the interlocking elements have eyelets. Tabs extend into the eyelets to mate with holes in the posts.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: March 7, 2017
    Assignee: BOSTON SCIENTIFIC SCIMED, INC.
    Inventors: Amr Salahieh, Brian D. Brandt, Dwight P. Morejohn, Ulrich R. Haug, Jean-Pierre Dueri, Hans F. Valencia, Robert A. Geshlider, Jeff A. Krolik
  • Patent number: 9585779
    Abstract: Segmented scaffolds composed of disconnected scaffold segments with overlapping end rings are disclosed. Scaffolds with at least one discontinuous link are also disclosed.
    Type: Grant
    Filed: July 16, 2014
    Date of Patent: March 7, 2017
    Assignee: ABBOTT CARDIOVASCULAR SYSTEMS INC.
    Inventors: John E. Papp, Syed Faiyaz Ahmed Hossainy, Michael Ngo, Chad Abunassar, Boris Anukhin, Mikael Trollsas, Lewis B. Schwartz